title: [Triptolide-eluting stent prevents porcine coronary artery in-stent restenosis by affecting PCNA and P27(kip1) expression].
abstract: OBJECTIVE
  To investigate the effectiveness and safety of triptolide-eluting stents implanted in porcine coronary arteries for restenosis prevention, and its effect on the expression of proliferating cell nuclear antigen (PCNA) and P27(kip1).
  
  
  METHODS
  Ten triptolide-eluting stents and 10 stainless steel stents (control) were implanted in 20 porcine coronary arteries at random. Four weeks later, angiography of the arteries was performed along with also histopathological and immunochemical examinations.
  
  
  RESULTS
  The in-stent minimal lumen diameter of triptolide group was significantly greater, and the neointimal area significantly smaller, than those of the control group (P<0.05). PCNA expression was significantly lower while P27(kip1) protein significantly higher in triptolide group than in the control group (P<0.05).
  
  
  CONCLUSIONS
  Triptolide-eluting stent can effectively inhibit neointimal formation to prevent restenosis in porcine coronary artery 4 weeks after implantation, probably by inhibiting P27(kip1) expression and consequently vascular smooth muscle cell proliferation.
authors.affiliation: Department of Cardiology, Second Affiliated Hospital of Guangzhou Medical College, Guangzhou 510260, China. ldf1688@yahoo.com.cn
authors.forename: Dong-feng
authors.initials: DF
authors.lastname: Lu
authors.forename: Jing
authors.initials: J
authors.lastname: Huang
authors.forename: Hao
authors.initials: H
authors.lastname: Wu
authors.forename: Xiao
authors.initials: X
authors.lastname: Yuan
authors.forename: Li
authors.initials: L
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D023903:Coronary Restenosis / Q000517:prevention & control*; D003331:Coronary Vessels / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D050760:Cyclin-Dependent Kinase Inhibitor p27 / Q000096:biosynthesis*; D004224:Diterpenes / Q000627:therapeutic use*; D054855:Drug-Eluting Stents; D004852:Epoxy Compounds / Q000627:therapeutic use; D007150:Immunohistochemistry; D008297:Male; D010616:Phenanthrenes / Q000627:therapeutic use*; D018809:Proliferating Cell Nuclear Antigen / Q000096:biosynthesis*; D011897:Random Allocation; D013552:Swine; D013997:Time Factors; D017539:Tunica Intima / Q000187:drug effects / Q000378:metabolism / Q000473:pathology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004224:Diterpenes; D004852:Epoxy Compounds; D010616:Phenanthrenes; D018809:Proliferating Cell Nuclear Antigen; D050760:Cyclin-Dependent Kinase Inhibitor p27; C001899:triptolide